Literature DB >> 15102436

The glamour and gloom of glycogen synthase kinase-3.

Richard S Jope1, Gail V W Johnson.   

Abstract

Glycogen synthase kinase-3 (GSK3) is now recognized as a key component of a surprisingly large number of cellular processes and diseases. Several mechanisms play a part in controlling the actions of GSK3, including phosphorylation, protein complex formation, and subcellular distribution. These are used to control and direct the far-reaching influences of GSK3 on cellular structure, growth, motility and apoptosis. Dysregulation of GSK3 is linked to several prevalent pathological conditions, such as diabetes and/or insulin resistance, and Alzheimer's disease. Therefore, much effort is currently directed towards understanding the functions and control of GSK3, and identifying methods capable of diminishing the deleterious impact of GSK3 in pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102436     DOI: 10.1016/j.tibs.2003.12.004

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  586 in total

1.  O-linked beta-N-acetylglucosamine (O-GlcNAc) regulates stress-induced heat shock protein expression in a GSK-3beta-dependent manner.

Authors:  Zahra Kazemi; Hana Chang; Sarah Haserodt; Cathrine McKen; Natasha E Zachara
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy.

Authors:  Raquel Gómez-Sintes; José J Lucas
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

3.  GSK3 controls axon growth via CLASP-mediated regulation of growth cone microtubules.

Authors:  Eun-Mi Hur; Byoung Dae Lee; Seong-Jin Kim; Wen-Lin Xu; Feng-Quan Zhou
Journal:  Genes Dev       Date:  2011-09-15       Impact factor: 11.361

4.  AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3.

Authors:  Taj D King; Ling Song; Richard S Jope
Journal:  Biochem Pharmacol       Date:  2006-03-10       Impact factor: 5.858

5.  Glucagon-like peptide-1 cleavage product GLP-1(9-36) amide rescues synaptic plasticity and memory deficits in Alzheimer's disease model mice.

Authors:  Tao Ma; Xueliang Du; Joseph E Pick; Guangzhi Sui; Michael Brownlee; Eric Klann
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

6.  Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3.

Authors:  Rajakishore Mishra; Manoj K Barthwal; Gautam Sondarva; Basabi Rana; Lucas Wong; Malay Chatterjee; James R Woodgett; Ajay Rana
Journal:  J Biol Chem       Date:  2007-08-21       Impact factor: 5.157

7.  Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency.

Authors:  Taj D King; Buffie Clodfelder-Miller; Keri A Barksdale; Gautam N Bijur
Journal:  Neurotox Res       Date:  2008-12       Impact factor: 3.911

8.  Lithium prevents acrolein-induced neurotoxicity in HT22 mouse hippocampal cells.

Authors:  Yingjuan Huang; Jian Qin; Meihui Chen; Xiaojuan Chao; Ziwei Chen; Charles Ramassamy; Rongbiao Pi; Minghua Jin
Journal:  Neurochem Res       Date:  2014-02-13       Impact factor: 3.996

9.  Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice.

Authors:  Marjelo A Mines; Eleonore Beurel; Richard S Jope
Journal:  Eur J Pharmacol       Date:  2012-10-23       Impact factor: 4.432

10.  GSK3 alpha and beta are new functionally relevant targets of tivantinib in lung cancer cells.

Authors:  Lily L Remsing Rix; Brent M Kuenzi; Yunting Luo; Elizabeth Remily-Wood; Fumi Kinose; Gabriela Wright; Jiannong Li; John M Koomen; Eric B Haura; Harshani R Lawrence; Uwe Rix
Journal:  ACS Chem Biol       Date:  2013-11-20       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.